Oppenheimer upgraded Korro Bio (KRRO) to Outperform from Perform with a $22 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro Bio upgraded to Overweight from Neutral at Cantor Fitzgerald
- Korro Bio price target raised to $10 from $7 at Clear Street
- Korro Bio Showcases KRRO-121 RNA Editing Program Progress
- Korro Bio Updates Pipeline, Terminates KRRO-110 REWRITE Trial
- Korro Bio Enhances Executive Compensation and Retention Incentives